CV
Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
$1.19 -2.46% (-$0.03)
1M -38.66%
Market Cap $4.25M
P/E Ratio -
Div. Yield -
ROE 406.38%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.04x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 206.55%
ROIC 284.81%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 3.73x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
42 /100
Moderate Profitable years 0
Beta 1.84x
EPS volatility 17.65%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CVKD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Quang X. Pham
Employees
5
Headquarters
Ponte Vedra
Nadchodzące wydarzenia
09 LIS
Earnings
Upcoming earnings report